Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2648
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    47,961.40
    -666.00 (-1.37%)
     
  • CMC Crypto 200

    1,264.25
    -19.58 (-1.53%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.20 (-0.12%)
     
  • CRUDE OIL

    81.46
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,336.90
    +0.30 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.14 (+0.01%)
     
  • DAX

    18,235.45
    +24.90 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

Swedish Exchange Growth Companies With High Insider Ownership And 51% Earnings Growth

As global markets navigate through varying economic signals, Sweden's stock market remains a point of interest for investors looking for growth opportunities. Amidst this landscape, companies with high insider ownership and significant earnings growth stand out as potentially resilient choices in uncertain times.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

BioArctic (OM:BIOA B)

35.1%

50.9%

Sileon (OM:SILEON)

33.3%

109.3%

KebNi (OM:KEBNI B)

37.8%

90.4%

edyoutec (NGM:EDYOU)

14.6%

63.1%

Biovica International (OM:BIOVIC B)

12.7%

73.8%

Calliditas Therapeutics (OM:CALTX)

11.6%

52.9%

Egetis Therapeutics (OM:EGTX)

17.6%

98.2%

Yubico (OM:YUBICO)

37.5%

43.4%

SaveLend Group (OM:YIELD)

24.9%

103.4%

Click here to see the full list of 84 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

ADVERTISEMENT

Let's review some notable picks from our screened stocks.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ), based in Sweden, focuses on the development of biological drugs for central nervous system disorders and has a market capitalization of SEK 20.03 billion.

Operations: The company generates revenue primarily from its biotechnology segment, totaling SEK 252.21 million.

Insider Ownership: 35.1%

Earnings Growth Forecast: 50.9% p.a.

BioArctic, a Swedish biopharmaceutical company, is expected to see significant revenue growth at 40.8% annually, outpacing the Swedish market's 1.8%. Despite recent financial setbacks with a substantial net loss reported in Q1 2024, the company is projected to become profitable within three years. Insider transactions have not been substantial in volume recently. Noteworthy is BioArctic's strategic alliance with Eisai Co., enhancing its Alzheimer’s disease portfolio, including the newly approved Leqembi® in South Korea.

OM:BIOA B Ownership Breakdown as at Jun 2024
OM:BIOA B Ownership Breakdown as at Jun 2024

AB Sagax

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AB Sagax (publ) is a property company with operations across Sweden, Finland, France, Benelux, Spain, Germany, and other European countries, boasting a market capitalization of approximately SEK 93.29 billion.

Operations: The company generates its revenue primarily from real estate rentals, amounting to SEK 4.47 billion.

Insider Ownership: 28.3%

Earnings Growth Forecast: 33.4% p.a.

AB Sagax, a Swedish property investment firm, has recently engaged in substantial fixed-income offerings totaling nearly €500 million to support its green initiatives. Despite this proactive financial strategy, the company's debt is poorly covered by operating cash flow. However, AB Sagax has demonstrated robust growth with a significant 53.3% increase in earnings over the past year and is forecasted to continue this trend with earnings expected to grow at 33.4% annually, outperforming the Swedish market prediction of 14%. This growth comes amidst no substantial insider trading activity in recent months and some shareholder dilution within the last year.

OM:SAGA A Earnings and Revenue Growth as at Jun 2024
OM:SAGA A Earnings and Revenue Growth as at Jun 2024

Wallenstam

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Wallenstam AB (publ) is a Swedish property company with a market capitalization of approximately SEK 32.95 billion.

Operations: The company generates its revenue primarily from two segments: SEK 920 million from Stockholm and SEK 1.89 billion from Gothenburg.

Insider Ownership: 35%

Earnings Growth Forecast: 51.3% p.a.

Wallenstam AB has shown promising signs of growth with a recent surge in net income to SEK 333 million from SEK 48 million year-over-year, and a robust increase in basic earnings per share. Despite this, the company faces challenges as its interest payments are not well covered by earnings. However, it benefits from higher insider buying than selling recently, supporting investor confidence despite a dividend reduction to SEK 0.50 per share for 2023. Wallenstam's revenue growth is expected to outpace the Swedish market slightly at 3% annually.

OM:WALL B Ownership Breakdown as at Jun 2024
OM:WALL B Ownership Breakdown as at Jun 2024

Where To Now?

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:BIOA B OM:SAGA A and OM:WALL B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com